臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 596-620 / 1656 (共67頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-01-28T01:06:53Z	P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection	Liang J.-T.;Huang K.-C.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Wang S.-M.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Wang S.-M.; Chang K.-J.
臺大學術典藏	2021-01-28T01:06:53Z	Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma	Huang C.-L.;Lin Z.-Z.;Su I.-J.;Chao T.-Y.;Tien H.-F.;Chang M.-C.;Huang M.-C.;Kao W.-Y.;Tang J.-L.;Kun-Huei Yeh;Wang C.-H.;Hsu C.-H.;Liu M.-Y.;Cheng A.-L.; Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; Tang J.-L.; KUN-HUEI YEH; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:52Z	A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil	Hsu C.-H.;Cheng A.-L.;Hsu C.;Yang C.-H.;Lu Y.-S.;Lin C.-C.;Bu C.-F.;Kun-Huei Yeh; Hsu C.-H.; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; KUN-HUEI YEH
臺大學術典藏	2021-01-28T01:06:52Z	High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection	Liang J.-T.;Huang K.-C.;Lai H.-S.;Lee P.-H.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Wang S.-M.;Tang C.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Wang S.-M.; Tang C.; Chang K.-J.
臺大學術典藏	2021-01-28T01:06:50Z	Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma	Lu Y.-S.;Hsu C.;Li C.-C.;Kuo S.-H.;Kun-Huei Yeh;Yang C.-H.;Hsu C.-H.;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; KUN-HUEI YEH; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:50Z	Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract	Hsu C.;Shen Y.-C.;Yang C.-H.;Kun-Huei Yeh;Lu Y.-S.;Hsu C.-H.;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Hsu C.; Shen Y.-C.; Yang C.-H.; KUN-HUEI YEH; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:49Z	Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer	Kun-Huei Yeh;Lu Y.S.;Hsu C.H.;Lin J.F.;Chao H.J.;Huang T.C.;Chung C.Y.;Chang C.S.;Yang C.H.;Cheng A.L.; KUN-HUEI YEH; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L.
臺大學術典藏	2021-01-28T01:06:48Z	Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer	Kun-Huei Yeh;Lu Y.-S.;Hsu C.-H.;Lin J.-F.;Hsu C.;Kuo S.-H.;Li Jr. S.;Cheng A.-L.; KUN-HUEI YEH; Lu Y.-S.; Hsu C.-H.; Lin J.-F.; Hsu C.; Kuo S.-H.; Li Jr. S.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:48Z	Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment	Yang C.-H.;Chen M.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Yu Y.-C.;Whang-Peng J.;Yang P.-C.; Yang C.-H.; Chen M.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Yu Y.-C.; Whang-Peng J.; Yang P.-C.
臺大學術典藏	2021-01-28T01:06:47Z	A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus	Pei Y.Y.;Kuo S.-H.;Kun-Huei Yeh;Chuang S.-E.;Hsu C.-H.;Wen C.C.;Lin H.-I.;Gao M.;Cheng A.-L.; Pei Y.Y.; Kuo S.-H.; KUN-HUEI YEH; Chuang S.-E.; Hsu C.-H.; Wen C.C.; Lin H.-I.; Gao M.; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:46Z	Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer	Lin C.-C.;Hsu C.-H.;Cheng J.C.;Wang H.-P.;Lee J.-M.;Kun-Huei Yeh;Yang C.-H.;Lin J.-T.;Cheng A.-L.;Lee Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; KUN-HUEI YEH; Yang C.-H.; Lin J.-T.; Cheng A.-L.; Lee Y.-C.
臺大學術典藏	2021-01-28T01:06:45Z	Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma	Lin C.-C.;Kun-Huei Yeh;Yang C.-H.;Hsu C.;Tsai Y.-C.;Hsu W.-L.;Cheng A.-L.;Hsu C.-H.; Lin C.-C.; KUN-HUEI YEH; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-01-28T01:06:45Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Lin C.-C.;Cheng A.-L.;Hsu C.-H.;Lu Y.-S.;Hsu C.;Kun-Huei Yeh;Wu C.-Y.;Huang C.-S.;Yang C.-H.; Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; Hsu C.; KUN-HUEI YEH; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏	2021-01-28T01:06:44Z	Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation	Huang T.-C.; KUN-HUEI YEH; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-01-28T01:06:42Z	Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001	Kuo S.-H.;Hsu C.-H.;Chen L.-T.;Lu Y.-S.;Lin C.-H.;Yeh P.-Y.;Jeng H.-J.;Gao M.;Kun-Huei Yeh;Cheng A.-L.; Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH; Cheng A.-L.
臺大學術典藏	2021-01-28T01:06:40Z	T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement	Kuo S.-H.;Cheng A.-L.;Lin C.-W.;Hsu C.-H.;Wu M.-S.;Kun-Huei Yeh;Tzeng Y.-S.;Chen L.-T.; Kuo S.-H.; Cheng A.-L.; Lin C.-W.; Hsu C.-H.; Wu M.-S.; KUN-HUEI YEH; Tzeng Y.-S.; Chen L.-T.
臺大學術典藏	2021-01-28T01:06:39Z	Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer	Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; Hsu C.; Cheng W.-F.; Lin Y.-L.; Cheng A.-L.; KUN-HUEI YEH
臺大學術典藏	2021-01-28T01:06:36Z	Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy	Chen W.-W.;Lin C.-C.;Huang T.-C.;Cheng A.-L.;Kun-Huei Yeh;Hsu C.-H.; Chen W.-W.; Lin C.-C.; Huang T.-C.; Cheng A.-L.; KUN-HUEI YEH; Hsu C.-H.
臺大學術典藏	2021-01-28T01:06:32Z	A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies	Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; KUN-HUEI YEH; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H.
臺大學術典藏	2021-01-28T01:06:29Z	Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan	Shao Y.-Y.; Hsu C.-H.; KUN-HUEI YEH; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S.
臺大學術典藏	2021-01-28T01:06:28Z	Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma	Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Kun-Huei Yeh;Cheng A.-L.;Hsu C.-H.; Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; KUN-HUEI YEH; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-01-28T01:06:27Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	Yang S.-H.; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; KUN-HUEI YEH; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2021-01-28T01:06:20Z	Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy	Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Kun-Huei Yeh;Hsu C.-H.;Lee J.-M.; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; KUN-HUEI YEH; Hsu C.-H.; Lee J.-M.
臺大學術典藏	2021-01-28T01:06:17Z	Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma	Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Kun-Huei Yeh;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.; Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; KUN-HUEI YEH; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H.
臺大學術典藏	2021-01-26T02:55:12Z	Developmental function of very-low-birth-weight infants and full-term infants in early childhood	PEI-SHAN CHEN; Jeng S.-F.; Tsou K.-I.; Wang A.-H.; Hsu C.-J.; Lu L.; Hsu C.-H.; Tsou K.-S.; Fang L.-J.; Wang M.; Huang S.-H.; Chen L.-C.; Wu C.-S.; Yu S.-Y.; Kou Y.-W.; Mao S.-Y.

顯示項目 596-620 / 1656 (共67頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52910595 線上人數 : 851 教育部委託研究計畫計畫執行:國立臺灣大學圖書館